Alberto Martinez-Arizala, MD

Dr Kazandjian is a hematologic oncologist and clinician-scientist whose clinical research focuses on multiple myeloma and its precursor plasma cell dyscrasias (monoclonal gammopathy of unknown significance (MGUS) and smoldering myeloma). Dr Kazandjian has a particularly strong interest in identifying high-risk smoldering myeloma patients who may benefit from early treatment strategies and the development of early-interventional clinical trials targeting this patient population. In addition, his translational research interests lie in the development of modern and novel laboratory techniques, including next generation sequencing (NGS) to advance monitoring of minimal residual disease (MRD) and the immune cell repertoire during treatment.

Dr. David M. Roth, MD, is affiliated with the Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute, which are renowned elements of the University of Miami Health System. The cancer center is the only NCI-Designated Cancer Center in South Florida, while the eye institute is consistently ranked #1 in the USA for ophthalmology by U.S. News & World Report. The University of Miami Health System offers a diverse array of services across multiple specialties, from cancer care to ophthalmology, internal medicine, and more, ensuring comprehensive medical support. Patients can access innovative treatments and programs delivered by world-class physicians dedicated to advancing healthcare through academic excellence. Generated from the website